Clinical-stage biotechnology company; designs and develops human enzyme therapeutics
S. 4348, the FDASLA Act of 2022 H.R. 7667, the Food and Drug Amendments of 2022 S. 4071, the Helping Experts Accelerate Rare Treatments (HEART) Act H.R. 1184, the Helping Experts Accelerate Rare Treatments (HEART) Act S. 670/H.R. 1730, the Speeding Therapy Access Today (STAT) Act H.R. 6000, the Cures 2.0 Act S. 373/H.R. 4472, the Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act
PHA - Pharmacy
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE KPM GROUP DC LLC
1455 PENNSYLVANIA AVE NW, Unit 1150, Washington, DC, 20004, US
KATHERINE LANDES